scc9 cells Search Results


scc9  (CLS Cell Lines Service GmbH)
96
CLS Cell Lines Service GmbH scc9
Scc9, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc9+cells/SCC-9/pm36980544-49-6-35
Average 96 stars, based on 1 article reviews
scc9 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
chuk scc-9 cells  (BioResource International Inc)
90
BioResource International Inc chuk scc-9 cells
Chuk Scc 9 Cells, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc9+cells/chuk+scc+9+cells/pmc05399578__thnov07p1088s1-68-5-11
Average 90 stars, based on 1 article reviews
chuk scc-9 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
scc-9 cells  (Becton Dickinson)
90
Becton Dickinson scc-9 cells
Scc 9 Cells, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc9+cells/scc+9+cells/pmc06566103-78-1-22
Average 90 stars, based on 1 article reviews
scc-9 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
scc9  (European Collection of Authenticated Cell Cultures)
90
European Collection of Authenticated Cell Cultures scc9
(A) qRT-PCR results showing decrease in SPARC expression on GCDH-knockdown in BICR10 cells (B) Immunoblot showing the reduced expression of SPARC upon GCDH-knockdown in <t>SCC9</t> cells. (C) Decrease in H3K27Cr levels on SPARC promoter in sh GCDH BICR10 cells. (D) Immunoblot showing the reduced expression of GCDH on SP1-knockdown in BICR10 cells. (E) Plot showing SP1 binding on GCDH promoter in SP1-ChIP assay in BICR10. (F) IF images showing reduced nuclear localization in sh YEATS2 BICR10 cells. Scale bar, μm. (G) Immunoblot depicting decreased SPARC expression on SP1 knockdown and its subsequent rescue upon YEATS2 and GCDH overexpression in sh SP1 BICR10 cells. Error bars, mean ± SEM; two-tailed t test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, n = 3 biological replicates.
Scc9, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc9+cells/scc9/bio_rxiv__2024__09__24__614679-188-9-13
Average 90 stars, based on 1 article reviews
scc9 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
cell line scc9  (VivaCell Biotechnology GmbH)
90
VivaCell Biotechnology GmbH cell line scc9
(A) qRT-PCR results showing decrease in SPARC expression on GCDH-knockdown in BICR10 cells (B) Immunoblot showing the reduced expression of SPARC upon GCDH-knockdown in <t>SCC9</t> cells. (C) Decrease in H3K27Cr levels on SPARC promoter in sh GCDH BICR10 cells. (D) Immunoblot showing the reduced expression of GCDH on SP1-knockdown in BICR10 cells. (E) Plot showing SP1 binding on GCDH promoter in SP1-ChIP assay in BICR10. (F) IF images showing reduced nuclear localization in sh YEATS2 BICR10 cells. Scale bar, μm. (G) Immunoblot depicting decreased SPARC expression on SP1 knockdown and its subsequent rescue upon YEATS2 and GCDH overexpression in sh SP1 BICR10 cells. Error bars, mean ± SEM; two-tailed t test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, n = 3 biological replicates.
Cell Line Scc9, supplied by VivaCell Biotechnology GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc9+cells/cell+line+scc9/10__1097_slash_cm9__0000000000003217-53-3-14
Average 90 stars, based on 1 article reviews
cell line scc9 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
scc9 cells  (iCell Bioscience Inc)
90
iCell Bioscience Inc scc9 cells
(A) qRT-PCR results showing decrease in SPARC expression on GCDH-knockdown in BICR10 cells (B) Immunoblot showing the reduced expression of SPARC upon GCDH-knockdown in <t>SCC9</t> cells. (C) Decrease in H3K27Cr levels on SPARC promoter in sh GCDH BICR10 cells. (D) Immunoblot showing the reduced expression of GCDH on SP1-knockdown in BICR10 cells. (E) Plot showing SP1 binding on GCDH promoter in SP1-ChIP assay in BICR10. (F) IF images showing reduced nuclear localization in sh YEATS2 BICR10 cells. Scale bar, μm. (G) Immunoblot depicting decreased SPARC expression on SP1 knockdown and its subsequent rescue upon YEATS2 and GCDH overexpression in sh SP1 BICR10 cells. Error bars, mean ± SEM; two-tailed t test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, n = 3 biological replicates.
Scc9 Cells, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc9+cells/scc9+cells/pm40045362-81-6-12
Average 90 stars, based on 1 article reviews
scc9 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
oral cancer scc9 cell lines  (National Centre for Cell Science)
90
National Centre for Cell Science oral cancer scc9 cell lines
(A) qRT-PCR results showing decrease in SPARC expression on GCDH-knockdown in BICR10 cells (B) Immunoblot showing the reduced expression of SPARC upon GCDH-knockdown in <t>SCC9</t> cells. (C) Decrease in H3K27Cr levels on SPARC promoter in sh GCDH BICR10 cells. (D) Immunoblot showing the reduced expression of GCDH on SP1-knockdown in BICR10 cells. (E) Plot showing SP1 binding on GCDH promoter in SP1-ChIP assay in BICR10. (F) IF images showing reduced nuclear localization in sh YEATS2 BICR10 cells. Scale bar, μm. (G) Immunoblot depicting decreased SPARC expression on SP1 knockdown and its subsequent rescue upon YEATS2 and GCDH overexpression in sh SP1 BICR10 cells. Error bars, mean ± SEM; two-tailed t test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, n = 3 biological replicates.
Oral Cancer Scc9 Cell Lines, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc9+cells/oral+cancer+scc9+cell+lines/pm39907519-135-0-9
Average 90 stars, based on 1 article reviews
oral cancer scc9 cell lines - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
stable mg53 overexpression/knockdown scc9 and scc25 cells  (Verlag GmbH)
90
Verlag GmbH stable mg53 overexpression/knockdown scc9 and scc25 cells
(A) qRT-PCR results showing decrease in SPARC expression on GCDH-knockdown in BICR10 cells (B) Immunoblot showing the reduced expression of SPARC upon GCDH-knockdown in <t>SCC9</t> cells. (C) Decrease in H3K27Cr levels on SPARC promoter in sh GCDH BICR10 cells. (D) Immunoblot showing the reduced expression of GCDH on SP1-knockdown in BICR10 cells. (E) Plot showing SP1 binding on GCDH promoter in SP1-ChIP assay in BICR10. (F) IF images showing reduced nuclear localization in sh YEATS2 BICR10 cells. Scale bar, μm. (G) Immunoblot depicting decreased SPARC expression on SP1 knockdown and its subsequent rescue upon YEATS2 and GCDH overexpression in sh SP1 BICR10 cells. Error bars, mean ± SEM; two-tailed t test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, n = 3 biological replicates.
Stable Mg53 Overexpression/Knockdown Scc9 And Scc25 Cells, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc9+cells/stable+mg53+overexpression+knockdown+scc9+and+scc25+cells/pm30690890-67-25-12
Average 90 stars, based on 1 article reviews
stable mg53 overexpression/knockdown scc9 and scc25 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
scc9 cells  (Charles River Laboratories)
86
Charles River Laboratories scc9 cells
(A) qRT-PCR results showing decrease in SPARC expression on GCDH-knockdown in BICR10 cells (B) Immunoblot showing the reduced expression of SPARC upon GCDH-knockdown in <t>SCC9</t> cells. (C) Decrease in H3K27Cr levels on SPARC promoter in sh GCDH BICR10 cells. (D) Immunoblot showing the reduced expression of GCDH on SP1-knockdown in BICR10 cells. (E) Plot showing SP1 binding on GCDH promoter in SP1-ChIP assay in BICR10. (F) IF images showing reduced nuclear localization in sh YEATS2 BICR10 cells. Scale bar, μm. (G) Immunoblot depicting decreased SPARC expression on SP1 knockdown and its subsequent rescue upon YEATS2 and GCDH overexpression in sh SP1 BICR10 cells. Error bars, mean ± SEM; two-tailed t test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, n = 3 biological replicates.
Scc9 Cells, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc9+cells/cells+scc9/10__1515_slash_oncologie___2024___0272-105-0-20
Average 86 stars, based on 1 article reviews
scc9 cells - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
scc-9 [scc 9; scc9] cell complete medium  (Elabscience Biotechnology)
N/A
   Buy from Supplier
scc9 gfp reporter cell line  (AcceGen Biotechnology)
N/A
The SCC9 GFP cell line is transformed from SCC9 cell, expressing the GFP gene. The cell constitutively express GFP.
   Buy from Supplier
scc9 luciferase reporter cell line  (AcceGen Biotechnology)
N/A
The SCC9 Luciferase cell line is transformed from SCC9 cell, expressing the firefly luciferase gene. The cell constitutively express Luciferase.
   Buy from Supplier

Image Search Results


(A) qRT-PCR results showing decrease in SPARC expression on GCDH-knockdown in BICR10 cells (B) Immunoblot showing the reduced expression of SPARC upon GCDH-knockdown in SCC9 cells. (C) Decrease in H3K27Cr levels on SPARC promoter in sh GCDH BICR10 cells. (D) Immunoblot showing the reduced expression of GCDH on SP1-knockdown in BICR10 cells. (E) Plot showing SP1 binding on GCDH promoter in SP1-ChIP assay in BICR10. (F) IF images showing reduced nuclear localization in sh YEATS2 BICR10 cells. Scale bar, μm. (G) Immunoblot depicting decreased SPARC expression on SP1 knockdown and its subsequent rescue upon YEATS2 and GCDH overexpression in sh SP1 BICR10 cells. Error bars, mean ± SEM; two-tailed t test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, n = 3 biological replicates.

Journal: bioRxiv

Article Title: Interplay of YEATS2 and GCDH mediates histone crotonylation and drives EMT in head and neck cancer

doi: 10.1101/2024.09.24.614679

Figure Lengend Snippet: (A) qRT-PCR results showing decrease in SPARC expression on GCDH-knockdown in BICR10 cells (B) Immunoblot showing the reduced expression of SPARC upon GCDH-knockdown in SCC9 cells. (C) Decrease in H3K27Cr levels on SPARC promoter in sh GCDH BICR10 cells. (D) Immunoblot showing the reduced expression of GCDH on SP1-knockdown in BICR10 cells. (E) Plot showing SP1 binding on GCDH promoter in SP1-ChIP assay in BICR10. (F) IF images showing reduced nuclear localization in sh YEATS2 BICR10 cells. Scale bar, μm. (G) Immunoblot depicting decreased SPARC expression on SP1 knockdown and its subsequent rescue upon YEATS2 and GCDH overexpression in sh SP1 BICR10 cells. Error bars, mean ± SEM; two-tailed t test, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, n = 3 biological replicates.

Article Snippet: Human head and neck cancer cell lines BICR10 and SCC9 were obtained from European Collection of Authenticated Cell Cultures (ECACC).

Techniques: Quantitative RT-PCR, Expressing, Knockdown, Western Blot, Binding Assay, Over Expression, Two Tailed Test